B01AB01 • heparin • Blood and blood forming organs | Antithrombotic agents | Heparin group
Heparin is an anticoagulant used for the prevention and treatment of deep vein thrombosis, pulmonary embolism, and other thromboembolic conditions. It works by inhibiting blood clot formation.
The medication is administered subcutaneously or intravenously, as directed by a doctor. It is important to monitor coagulation parameters during treatment.
Side effects may include bleeding, injection site reactions, or, in rare cases, heparin-induced thrombocytopenia.
Heparin is not recommended for patients with hypersensitivity to this medication, severe coagulation disorders, or active bleeding.
Substance: heparin
Date of last drug list: 01-08-2024
Commercial code: W70367001
Concentration: 500UI / ml
Pharmaceutical form: injectible solution
Quantity: 100
Product type: generic
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).
Manufacturer: ROVI PHARMA INDUSTRIAL SERVICES, S.A - SPANIA
Holder: ANISAPHARM DISTRIBUTION S.R.L. - ROMANIA
Number: 15512/2024/01
Shelf life: 3 years